Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
5.95
+0.18 (3.12%)
At close: Sep 11, 2024, 4:00 PM
6.07
+0.12 (1.97%)
After-hours: Sep 11, 2024, 6:13 PM EDT
Personalis Market Cap
Personalis has a market cap or net worth of $337.35 million as of September 11, 2024. Its market cap has increased by 363.39% in one year.
Market Cap
337.35M
Enterprise Value
297.04M
1-Year Change
363.39%
Ranking
Category
Stock Price
$5.95
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $811.90M to $337.35M, a decrease of -58.45%. That is a compound annual growth rate of -15.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2024 | 306.20M | 197.28% |
| Dec 29, 2023 | 103.00M | 13.19% |
| Dec 30, 2022 | 91.00M | -85.76% |
| Dec 31, 2021 | 639.10M | -55.16% |
| Dec 31, 2020 | 1.43B | 318.59% |
| Dec 31, 2019 | 340.50M | -58.06% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 344.88M |
| Voyager Therapeutics | 342.47M |
| Esperion Therapeutics | 341.43M |
| Organogenesis Holdings | 339.39M |
| Lexeo Therapeutics | 338.54M |
| ClearPoint Neuro | 336.94M |
| Cartesian Therapeutics | 331.64M |
| Sight Sciences | 331.02M |